Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface
- 16 January 2009
- journal article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 22 (1) , 86-98
Abstract
Summary: Brain metastases are a common feature of malignant melanoma and are associated with poor prognosis. Melanotransferrin (MTf), one of several antigens associated with the surface of melanoma cells, has been demonstrated to promote cell invasion. In this study, we investigated the role of membrane‐bound MTf in several of the steps leading to the development of melanoma brain metastasis. Our results indicated that MTf‐positive cells were detected in the brains of nude mice injected intravenously with human melanoma SK‐Mel 28 cells. Moreover, administration of a single dose of a monoclonal antibody (L235) directed against human MTf significantly reduced the development of human melanoma brain metastases in nude mice. The ability of melanoma cells to cross the blood–brain barrier (BBB) in vitro is correlated with their MTf expression levels at the cell surface. Overall, our results indicated that membrane‐bound MTf is a key element in melanoma cell transmigration across the BBB and subsequent brain metastasis. Thus, these data suggest MTf as an attractive target and demonstrate the therapeutic potential of an anti‐MTf mAb for preventing metastatic melanoma.Keywords
This publication has 43 references indexed in Scilit:
- Inhibition of tumor growth by a truncated and soluble form of melanotransferrinExperimental Cell Research, 2007
- Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivoBiochemical and Biophysical Research Communications, 2007
- In vivo inhibition of angiogenesis by a soluble form of melanotransferrinCarcinogenesis, 2006
- Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachmentBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: A key phenomenon for cell invasionExperimental Cell Research, 2005
- Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic systemBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Examination of the distribution of the transferrin homologue, melanotransferrin (tumour antigen p97), in mouse and humanBiochimica et Biophysica Acta (BBA) - General Subjects, 2005
- Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance SystemJournal of Clinical Oncology, 2004
- Blood-Brain Barrier Disruption and Matrix Metalloproteinase-9 Expression During Reperfusion InjuryStroke, 2002
- A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumorsJournal of Neuro-Oncology, 1994